Biomedical start-up Adapttech has raised £2 million in a new venture capital funding round. The round was supported by existing investors including the MEIF Proof of Concept & Early Stage Fund, Bionova Capital, as well as new investors including ACF Investors, Wealth Club and Wren Capital.
The new funding will be primarily be used for new product developments, and to drive sales of the company’s Insight system, which makes it faster and easier to correctly fit lower-limb prostheses and monitor the rehabilitation process.
Frederico Carpinteiro, founder, Adapttech, said: “We’re delighted to have secured significant investment from both existing and new investors as we seek to drive sales of Insight. The funding will also support our plans to develop and release new products, hire key personnel, and prepare our production processes for scale.”
Insight combines a 3D scanner, sensors, wearable technology and a mobile app to make it faster and easier to reach a comfortably fitting prostheses socket and monitor a patient’s rehabilitation process. Insight is now generally available, following successful outcome studies at two prosthetics clinics in the United States, where validated tests for health, function, satisfaction and pain level were used to verify the effectiveness of the Insight system.
Stuart Mead, chairman, Adapttech, said: “This new funding is a significant milestone for Adapttech, as it represents the company’s transition from its development and testing phase into a fully commercial operation. I’m delighted to say that there was strong interest from investors, both new and existing, and we’re looking forward to making the next year a landmark one for this company.”
The Midlands Engine Investment Fund project is supported financially by the European Union using funding from the European Regional Development Fund (ERDF) as part of the European Structural and Investment Funds Growth Programme 2014-2020 and the European Investment Bank.
